Abivax Highlights Obefazimod Ulcerative Colitis Program With New Data to be Presented at the UEG Week 2023 dallassun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallassun.com Daily Mail and Mail on Sunday newspapers.
Oral presentation of Phase 2b, 96-week, open-label, maintenance efficacy and safety in obefazimod-treated patients with moderately to severely active ulcerative colitis (UC)Moderated poster presentation highlighting correlation of pharmacokinetic .
EQS-News: ABIVAX / Key word: Study results
Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023
02.10.2023.